These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
3. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Fung SY; Yuen KS; Ye ZW; Chan CP; Jin DY Emerg Microbes Infect; 2020; 9(1):558-570. PubMed ID: 32172672 [TBL] [Abstract][Full Text] [Related]
4. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]
5. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana. Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899 [TBL] [Abstract][Full Text] [Related]
7. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998 [TBL] [Abstract][Full Text] [Related]
8. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2). Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241 [TBL] [Abstract][Full Text] [Related]
9. The Coronavirus Pandemic: What Does the Evidence Show? Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585 [TBL] [Abstract][Full Text] [Related]
10. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain. Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V F1000Res; 2020; 9():576. PubMed ID: 32802318 [No Abstract] [Full Text] [Related]
12. Ca Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V Elife; 2020 May; 9():. PubMed ID: 32452762 [TBL] [Abstract][Full Text] [Related]
14. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review. Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808 [TBL] [Abstract][Full Text] [Related]
15. Towards a more effective strategy for COVID-19 prevention (Review). Szkaradkiewicz-Karpińska AK; Szkaradkiewicz A Exp Ther Med; 2021 Jan; 21(1):33. PubMed ID: 33262819 [TBL] [Abstract][Full Text] [Related]
16. Behbahani M; Mohabatkar H; Hosseini B Inform Med Unlocked; 2021; 26():100757. PubMed ID: 34664030 [TBL] [Abstract][Full Text] [Related]
17. Advancements in Rapid and Affordable Diagnostic Testing for Respiratory Infectious Diseases: Evaluation of Aptamer Beacon Technology for Rapid and Sensitive Detection of SAR-CoV-2 in Breath Condensate. Mirza AH; Akhtar M; Aguren J; Marino J; Bruno JG J Fluoresc; 2024 Nov; 34(6):2629-2640. PubMed ID: 37864614 [TBL] [Abstract][Full Text] [Related]
18. Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors. Peinetti AS; Lake RJ; Cong W; Cooper L; Wu Y; Ma Y; Pawel GT; Toimil-Molares ME; Trautmann C; Rong L; Mariñas B; Azzaroni O; Lu Y Sci Adv; 2021 Sep; 7(39):eabh2848. PubMed ID: 34550739 [TBL] [Abstract][Full Text] [Related]
19. Fluorescence-Linked Aptamer Assay for SARS-CoV-2 Spike-Protein: A Step-by-Step Performance Analysis in Clinical Samples. Franco-Urquijo PA; Sierra-Martínez M; Jarquín-Martínez M; Martínez-Roque MA; García-Velásquez VM; Acosta-Altamirano G; Ruiz-Pérez NJ; Toscano-Garibay JD; Alvarez-Salas LM Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428893 [TBL] [Abstract][Full Text] [Related]
20. Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2. Liu Y; Hu B; Li J; Pei X; Hu X Curr Med Chem; 2024; 31(3):273-279. PubMed ID: 37031389 [No Abstract] [Full Text] [Related] [Next] [New Search]